The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination
NCT03878706
·
clinicaltrials.gov ↗
RECRUITING
Status
240
Enrollment
OTHER
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Sponsor
University of Athens